What is Kinamed?
Kinamed Incorporated operates at the intersection of advanced engineering and clinical medicine, focusing on the development of high-performance medical products for orthopedics, cardiothoracic surgery, and neurosurgery. The company's portfolio, which includes proprietary technologies such as the SuperCable and the CarboJet CO Bone Preparation System, is engineered to address the rigorous demands of modern surgical environments. By prioritizing patient-matched solutions like the KineMatch PFR, Kinamed effectively bridges the gap between complex surgical requirements and improved clinical outcomes. Their market position is defined by a commitment to precision, quality, and the continuous evolution of tools that enhance surgical efficiency for healthcare institutions globally.
How much funding has Kinamed raised?
Kinamed has raised a total of $982K across 2 funding rounds:
Debt
$350K
Debt
$632K
Debt (2020): $350K with participation from PPP
Debt (2021): $632K led by PPP
Key Investors in Kinamed
PPP
Public-Private Partnership
Undisclosed Investor
An institutional backer focused on long-term growth and strategic development within the healthcare and life sciences sectors.
Undisclosed Investor
A specialized lender providing non-dilutive capital to high-growth companies in the medical device manufacturing space.
What's next for Kinamed?
With the recent infusion of capital, Kinamed is well-positioned to accelerate its research and development initiatives, potentially expanding its footprint in the neurosurgical and orthopedic markets. The company's strategic focus will likely shift toward scaling the manufacturing of its patient-matched systems and deepening its penetration into global healthcare networks. As the medical device industry faces increasing pressure for cost-effective, high-efficiency solutions, Kinamed's ability to integrate its innovative product suite into standard surgical workflows will be a primary driver of its future growth. The firm remains focused on maintaining its competitive edge through clinical validation and the expansion of its intellectual property portfolio, ensuring that its technological advancements remain at the forefront of surgical care.
See full Kinamed company page
